Cargando…

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine

The antidiabetic drug metformin has been proposed to affect non-alcoholic fatty liver disease (NAFLD) through its effects on intestinal microbiota and barrier function. However, so far most studies focused on long-term effects and more progressed disease stages. The aim of this study was to assess i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandt, Annette, Hernández-Arriaga, Angélica, Kehm, Richard, Sánchez, Victor, Jin, Cheng Jun, Nier, Anika, Baumann, Anja, Camarinha-Silva, Amélia, Bergheim, Ina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491483/ https://www.ncbi.nlm.nih.gov/pubmed/31040374 http://dx.doi.org/10.1038/s41598-019-43228-0

Ejemplares similares

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'
por: Brandt, Annette, et al.
Publicado: (2022)

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice
por: Rajcic, Dragana, et al.
Publicado: (2023)

Cognitive Alterations in Old Mice Are Associated with Intestinal Barrier Dysfunction and Induced Toll-like Receptor 2 and 4 Signaling in Different Brain Regions
por: Brandt, Annette, et al.
Publicado: (2023)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake
por: Nier, Anika, et al.
Publicado: (2019)

The Intestinal Barrier Dysfunction as Driving Factor of Inflammaging
por: Untersmayr, Eva, et al.
Publicado: (2022)

Fructose: a modulator of intestinal barrier function and hepatic health?
por: Staltner, Raphaela, et al.
Publicado: (2023)

Changes in Oral Microbial Ecology of C57BL/6 Mice at Different Ages Associated with Sampling Methodology
por: Hernández-Arriaga, Angélica, et al.
Publicado: (2019)

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
por: Nier, Anika, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects
por: Nier, Anika, et al.
Publicado: (2019)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
por: Jung, Finn, et al.
Publicado: (2021)

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Anethole Attenuates Enterotoxigenic Escherichia coli-Induced Intestinal Barrier Disruption and Intestinal Inflammation via Modification of TLR Signaling and Intestinal Microbiota
por: Yi, Qingyuan, et al.
Publicado: (2021)

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
por: Burger, Katharina, et al.
Publicado: (2023)

Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome
por: Ermolenko, Elena, et al.
Publicado: (2022)

Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
por: Liu, Qingya, et al.
Publicado: (2021)

Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
por: Sun, E., et al.
Publicado: (2023)

“Get the best out of what comes in” – adaptation of the microbiota of chamois (Rupicapra rupicapra) to seasonal forage availability in the Bavarian Alps
por: Dahl, Sarah-Alica, et al.
Publicado: (2023)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Blueberry Attenuates Liver Fibrosis, Protects Intestinal Epithelial Barrier, and Maintains Gut Microbiota Homeostasis
por: Yan, Zhiqiang, et al.
Publicado: (2019)

Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis
por: Jahn, Daniel, et al.
Publicado: (2019)

Glycerol Monolaurate Ameliorated Intestinal Barrier and Immunity in Broilers by Regulating Intestinal Inflammation, Antioxidant Balance, and Intestinal Microbiota
por: Kong, Linglian, et al.
Publicado: (2021)

Severe burn injury alters intestinal microbiota composition and impairs intestinal barrier in mice
por: Feng, Yanhai, et al.
Publicado: (2019)

Disruption of the Intestinal Mucosal Barrier Induced by High Fructose and Restraint Stress Is Regulated by the Intestinal Microbiota and Microbiota Metabolites
por: Yu, Jiayu, et al.
Publicado: (2023)

Effects on the Ileal Microbiota of Phosphorus and Calcium Utilization, Bird Performance, and Gender in Japanese Quail
por: Borda-Molina, Daniel, et al.
Publicado: (2020)

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs
por: Jung, Finn, et al.
Publicado: (2022)

Molecular Modulation of Intestinal Epithelial Barrier: Contribution of Microbiota
por: Sharma, Renu, et al.
Publicado: (2010)

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
por: Barbara, Giovanni, et al.
Publicado: (2021)

Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
por: Schneider, Kai Markus, et al.
Publicado: (2020)

Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity
por: Cruz-Lebrón, Angélica, et al.
Publicado: (2021)

Emodin Ameliorates Intestinal Dysfunction by Maintaining Intestinal Barrier Integrity and Modulating the Microbiota in Septic Mice
por: Zhang, Mina, et al.
Publicado: (2022)

Galactooligosaccharide Mediates NF-κB Pathway to Improve Intestinal Barrier Function and Intestinal Microbiota
por: Xi, Menglu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qdfoib0u4r3sg03k5lt2rgd6l9